| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | £ 7.26K | £ 7.28K | £ 1.95K | £ 0.00 | £ 0.00 |
| Gross Profit | £ 0.00 | £ 7.28K | £ 1.95K | £ 0.00 | £ 0.00 |
| Operating Income | £ -1.10M | £ -1.22M | £ -1.43M | £ -1.19M | £ -1.84M |
| EBITDA | £ -1.10M | £ -1.22M | £ -1.33M | £ -1.19M | £ -1.84M |
| Net Income | £ -1.21M | £ -1.06M | £ -1.27M | £ -1.03M | £ -1.54M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | £ 1.08M | £ 625.97K | £ 1.03M | £ 1.92M | £ 1.78M |
| Total Assets | £ 1.17M | £ 775.77K | £ 1.28M | £ 2.17M | £ 2.34M |
| Total Debt | £ 0.00 | £ 0.00 | £ 0.00 | £ 0.00 | £ 0.00 |
| Net Debt | £ -1.08M | £ -625.97K | £ -1.03M | £ -1.92M | £ -1.78M |
| Total Liabilities | £ 97.96K | £ 124.37K | £ 81.73K | £ 77.89K | £ 212.73K |
| Stockholders' Equity | £ 1.07M | £ 647.65K | £ 1.13M | £ 2.09M | £ 2.13M |
| Cash Flow | |||||
| Free Cash Flow | £ -1.16M | £ -971.50K | £ -1.21M | £ -828.26K | £ -1.77M |
| Operating Cash Flow | £ -1.16M | £ -971.50K | £ -1.21M | £ -828.26K | £ -1.77M |
| Investing Cash Flow | £ 0.00 | £ 0.00 | £ 781.00 | £ 0.00 | £ 0.00 |
| Financing Cash Flow | £ 1.61M | £ 570.36K | £ 315.90K | £ 963.77K | £ 677.00 |
N4 Pharma PLC (DE:0GO)
FRANKFURT:0GO
